• Revenue outside the war zone up +42%
• Overall Group growth of +5.3%
• Acceleration of commercial diversification
• Continuation of the innovation strategy
Intrasense (FR0011179886 – ALINS), specialist in medical imaging software solutions and designer of Myrian® (the “Group”), today announces its 2022 consolidated half-year results under IFRS.
Growth in turnover and first fruits of commercial investments
“The revenue growth recorded in the first half of 2022 is particularly notable in a geopolitical context impacted by the conflict in Ukraine, and confirms the development dynamic initiated in 2021 following the capital increase. says Nicolas Reymond, Group CEO.
“We are strengthening our positioning within our historical zones, China and France, and we are diversifying our activities through new geographies such as Brazil. This strategy of increasing market share and developing targeted markets will be pursued in the months to come.
Our innovation strategy, through the investments we make in R&D on our product lines in radiology and oncology, as well as the first results obtained, allow us to be confident about the continuation of our growth in the years to come. . adds Nicolas Reymond.